Drug intelligence / Profile preview

hydrocortisone + polymyxin b (Polfa Tarchomin)

Development stage
Unknown
Lead developer
Aquapak
Modality
Peptides, Small Molecules
Administration
Ophthalmic, Rectal
01

Overview

HydroPol is a combination pharmaceutical product typically formulated as an otic or ophthalmic suspension. It contains **hydrocortisone**, a corticosteroid with anti-inflammatory and antipruritic properties, and **polymyxin B sulfate**, a polypeptide antibiotic effective against Gram-negative bacteria, particularly *Pseudomonas aeruginosa*. The mechanism of action involves hydrocortisone binding to cytoplasmic glucocorticoid receptors, leading to the inhibition of inflammatory mediators and the reduction of edema and capillary permeability. Polymyxin B acts by binding to phospholipids in the bacterial cytoplasmic membrane, disrupting its integrity and causing leakage of intracellular components, which results in bactericidal activity. It is primarily indicated for the treatment of superficial bacterial infections of the external auditory canal (otitis externa) or ocular structures when a steroid is also required to manage inflammation.

Brand names
HydroPolHydro-PolOtosporinPolyspectran HC
Other names
hydrocortisone and polymyxin b sulfatehydrocortisone/polymyxin b
02

Targets

GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on hydrocortisone + polymyxin b (Polfa Tarchomin).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hydrocortisone + polymyxin b (Polfa Tarchomin).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call